Dipeptidyl Peptidase-4 at the Interface Between Inflammation and Metabolism
Dipeptidyl peptidase-4 (DPP4) is a serine protease that rapidly inactivates the incretin peptides, glucagon-like peptide-1, and glucose-dependent insulinotropic polypeptide to modulate postprandial islet hormone secretion and glycemia. Dipeptidyl peptidase-4 also has nonglycemic effects by controlli...
Main Authors: | Natasha A Trzaskalski, Evgenia Fadzeyeva, Erin E Mulvihill |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2020-03-01
|
Series: | Clinical Medicine Insights: Endocrinology and Diabetes |
Online Access: | https://doi.org/10.1177/1179551420912972 |
Similar Items
-
Serum and Adipose Dipeptidyl Peptidase 4 in Cardiovascular Surgery Patients: Influence of Dipeptidyl Peptidase 4 Inhibitors
by: Ikuko Shibasaki, et al.
Published: (2022-07-01) -
Effects of dipeptidyl-peptidase 4 inhibitor about vascular inflammation in a metabolic syndrome model.
by: Nicolas F Renna, et al.
Published: (2014-01-01) -
The Multiple Biological Functions of Dipeptidyl Peptidase-4 in Bone Metabolism
by: Qiu Yang, et al.
Published: (2022-05-01) -
The role of dipeptidyl peptidase-4 inhibitors
by: Lasserson, D, et al.
Published: (2012) -
The role of dipeptidyl peptidase-4 inhibitors.
by: Lasserson, D, et al.
Published: (2012)